Immunological Assays (ELISA) for the Detection of Ricin, Abrin, and Botulinum Toxins (IADRABT)

Opportunity snapshot. This Grants.gov announcement - Immunological Assays (ELISA) for the Detection of Ricin, Abrin, and Botulinum Toxins (IADRABT) - is cataloged under number BAA08-05 and tied to CFDA assistance listing 97.065, posted by Office of Procurement Operations - Grants Division. Grants.gov currently shows the opportunity as closed, first posted on April 28, 2008. The funding category is Discretionary, delivered as a grant.

Award economics. The award range on file is Varies by applicant. The agency has projected $2.5 million in total estimated funding for this announcement. It expects to issue 1 award. If the agency funds the expected 1 award from the $2.5 million estimated pool, the average award works out to roughly $2.5 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity is closed. Monitoring the parent program page is the most reliable way to catch re-announcements in the next funding cycle. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.